Evidence map›Paper›PMID 36814490›Full record

ArticleFrontiers in pharmacology2023

Metabolomics profiling to characterize cerebral ischemia-reperfusion injury in mice.

Qiong Chen, Ting Zhou, Jun-Jie Yuan, Xiao-Yi Xiong, Xue-Hui Liu, Zong-Ming Qiu, Lin-Lin Hu, Hui Lu, Qian He, Chang Liu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Exploring the Therapeutic Potential ofPharmaceuticals (Basel, Switzerland) · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Qiong ChenDepartment of Neurology, Xinqiao Hospital, The Army Medical University (Third Military Medical University), Chongqing, China.
Ting ZhouDepartment of Neurology, Xinqiao Hospital, The Army Medical University (Third Military Medical University), Chongqing, China.
Jun-Jie YuanDepartment of Neurology, Xinqiao Hospital, The Army Medical University (Third Military Medical University), Chongqing, China.
Xiao-Yi XiongDepartment of Neurology, Xinqiao Hospital, The Army Medical University (Third Military Medical University), Chongqing, China.
Xue-Hui LiuDepartment of Medicinal Chemistry, College of Pharmacy, The Army Medical University (Third Military Medical University), Chongqing, China.
Zong-Ming QiuDepartment of Neurology, Xinqiao Hospital, The Army Medical University (Third Military Medical University), Chongqing, China.
Lin-Lin HuDepartment of Neurology, Xinqiao Hospital, The Army Medical University (Third Military Medical University), Chongqing, China.
Hui LuDepartment of Neurology, Xinqiao Hospital, The Army Medical University (Third Military Medical University), Chongqing, China.
Qian HeDepartment of Neurology, Xinqiao Hospital, The Army Medical University (Third Military Medical University), Chongqing, China.
Chang LiuDepartment of Neurology, Xinqiao Hospital, The Army Medical University (Third Military Medical University), Chongqing, China.
Qing-Wu YangDepartment of Neurology, Xinqiao Hospital, The Army Medical University (Third Military Medical University), Chongqing, China.
Army Medical University · CNXinqiao Hospital · CNChengdu University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral ischemia, resulting from compromised blood flow, is one of the leading causes of death worldwide with limited therapeutic options. Potential deleterious injuries resulting from reperfusion therapies remain a clinical challenge for physicians. This study aimed to explore the metabolomic alterations during ischemia-reperfusion injury by employing metabolomic analysis coupled with gas chromatography time-of-flight mass spectrometry (GC-TOF-MS) and ultraperformance liquid chromatography quadrupole (UPLC/Q)-TOF-MS. Metabolomic data from mice subjected to middle cerebral artery occlusion (MCAO) followed by reperfusion (MCAO/R) were compared to those of the sham and MCAO groups. A total of 82 simultaneously differentially expressed metabolites were identified among each group. The top three major classifications of these differentially expressed metabolites were organic acids, lipids, and organooxygen compounds. Metabolomics pathway analysis was conducted to identify the underlying pathways implicated in MCAO/R. Based on impactor scores, the most significant pathways involved in the response to the reperfusion after cerebral ischemia were glycerophospholipid metabolism, linoleic acid metabolism, pyrimidine metabolism, and galactose metabolism. 17 of those 82 metabolites were greatly elevated in the MCAO/Reperfusion group, when compared to those in the sham and MCAO groups. Among those metabolites, glucose-6-phosphate 1, fructose-6-phosphate, cellobiose 2, o-phosphonothreonine 1, and salicin were the top five elevated metabolites in MCAO/R group, compared with the MCAO group. Glycolysis, the pentose phosphate pathway, starch and sucrose metabolism, and fructose and mannose degradation were the top four ranked pathways according to metabolite set enrichment analysis (MSEA). The present study not only advances our understanding of metabolomic changes among animals in the sham and cerebral ischemia groups with or without reperfusion

Indexed as

GC-TOF-MSischemic-reperfusionmetabolitesnon-targeted metabolomicsUPLC/Q-TOF-MS

Identifiers

PMID36814490
PMCPMC9939521
OpenAlexW4319322014

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.